Chinese Medicine - Modern Practice (252 pages)

Study of XS0601 on Preventing Restenosis 137
(P 0.05). Taking acute gain as covariances, both XS0601 and probucol
could markedly reduce angiographic late lumen loss and late lumen loss
resulting from intimal hyperplasia (P < 0.05, P < O.Ol), which is similar to
the morphometric analysis. LXS and HXS could also significantly increase
the arterial diameter at the time of follow-up and reduce late lumen loss
resulting from remodeling (P < 0.05, P < 0.01).
Table 10.9. Angiographic analysis.
Control Pro bucol LXS HXS
Diameter 2.20 f 0.33 2.05 f 0.33 2.22 f 0.49 2.12 f 0.34
(before, mm)
Diameter 2.66k0.34 2.49f0.30 2.75k0.47 2.62f0.45
(after, mm)
Diameter 1.34 k 0.82 1.75 f 0.47 1.97 +0.51* 2.03 f 0.30*
(follow-up, mm)
Acute gain (mm) 0.43 f 0.17 0.51 f 0.10 0.58 k 0.03 0.55 k 0.11
Late loss (mm) 1.32k0.71 0.74f0.39t 0.78k0.33t 0.59rt0.28t
Values are mean k SD. No values were significantly different between groups by ANOVA
(P > 0.05).
‘P < 0.05, tP < 0.01, significance versus control: comparison of group means after ANOVA
taking acute gain as covariance.